A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
This study has been completed.
University Diabetes & Endocrine Consultants
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
David M. Huffman MD, University Diabetes & Endocrine Consultants
First received: July 16, 2007
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2008|
|Primary Completion Date:||January 2008 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):